Publication
Are Anti-Receptor–Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?
Kahina Saker, Bruno Pozzetto, Antonin Bal, Martine Valette, Jean Baptiste Fassier, Carla Saade, Mary Anne Trabaud, Sophie Trouillet-Assant, Nicolas Guibert, Dulce Alfaiate, Amélie Massardier-Pilonchery, Virginie Pitiot, Florence Morfin-Sherpa, Bruno Lina, Cécile Barnel, Constance d'Aubarede, Vanessa Escuret, Laurence Josset, Hélène Lozano, Bouchra Mokdad, Fanny Joubert, Camille Mena
Clinical Chemistry, May 2022, Oxford University Press (OUP)
DOI: 10.1093/clinchem/hvac085